Prescient Therapeutics LimitedASX: PTX

PTX-100 trial advances following successful Phase 1b

Jul 27, 2021 at 3:16 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment